Description

While consumers have been increasingly interested in CBD, regulatory concerns may have producers taking different paths to market or exploring alternative ingredients.

Consumers are seeking more natural ways to address health challenges such as increased stress levels, sleep concerns, inflammation and much more. In recent years, this has seen a boom of products introduced containing hemp extracts, isolated cannabinoids, and related ingredients that can impact the body’s endocannabinoid system. This month, Vitafoods Insights focuses on cannabinoids and CBD, including whitespace, regulatory challenges, and research on efficacy.

Tune in to hear more about:

• How the endocannabinoid system regulates body functions from cognition to inflammation
• Concerns around the evolving regulatory market for cannabinoids
• Why palmitoylethaolamide (PEA), an endocannabinoid-like lipid mediator, may offer a different route to market
• Product quality and research as a cornerstone to delivering efficacious products
• Harvard Health Blog
• Grand View Research

Host: Heather Granato, vice president, content, Vitafoods

Guests:

• Mariko Hill, global innovation manager, Gencor Pacific
• Matteo Delbruck, CEO, Swiss Organic Partners

Sponsored by: Gencor and Swiss Organic Partners

Click here to listen to our other Thematic Podcast episodes 

If you like the show, make sure to subscribe and follow the Vitafoods Insights podcast. Feel free also to recommend the show to a friend that you think would enjoy it.

For more content from Vitafoods Insights, make sure to check our website:  https://www.vitafoodsinsights.com   

To learn more about sponsorships opportunities, click here and make sure to check our media kit.